Fecal microbiota transplantation in cases of clostridium difficile in adults
DOI:
https://doi.org/10.35381/s.v.v6i3.2289Keywords:
Microbiota, coliforms, clostridium difficile. (Source, DeCS).Abstract
Objective: To analyze through a systemic review the effectiveness of the TMF treatment in cases of Clostridium Difficele. Method: Systematic meta-review of studies published in the last 5 years in: PubMed, Scielo, Clinical Key, Cochrane Library, Scopus, Spinger and Google Scholar with keywords (MESH terms). Results and conclusions: Clostridium difficile is a gram-positive anaerobic bacillus associated with the majority of infections that trigger diarrhea in hospital environments, its solution is fecal microbiota transplantation, consisting of the introduction of fecal matter suspension, of a healthy body to another affected, this transplant can be given in different ways either by oral capsules or by colonoscopy. We found that TMF either by colonoscopy or by capsule turned out to be more effective than the intake of antibiotics, which is why patients decide to undergo this procedure.
Downloads
References
Merino Rivera José Alfonso, Taracena Pacheco Santiago, Díaz Greene Enrique Juan, Rodríguez Weber Federico Leopoldo. Microbiota intestinal: “el órgano olvidado”. [Intestinal microbiota: "the forgotten organ"]. Acta médica Grupo Ángeles. 2021.19(1): 92-100. https://n9.cl/ob5bv
Czepiel, J., Drozdz, M., Pituch, H, H. et al. Clostridium difficele infection: review. European Journal of Clinical Microbiology & Infectious Diseases. 2019 Abril 03; 38:1211–21. https://n9.cl/s3lfe
Castañeda Guillot Carlos. Trasplante de microbiota fecal. Revista Cubana Pediatría. [Fecal microbiota transplant. Cuban Pediatric Magazine]. 2019. 91(3): e829. https://pesquisa.bvsalud.org/portal/resource/pt/biblio-1093722
Chacon, A., Bermudes, L. y Rojas, M. Infección por Clostridium difficile y el papel del trasplante de microbiota fecal. [Clostridium difficile infection and the role of fecal microbiota transplantation]. Revista Médica Sinergia. 2021. 6(6):2215–5279. https://revistamedicasinergia.com/index.php/rms/article/view/681/1233%205.
Moscoso F, Simian D, Rivera D, Acuña G, Quera R. Transplante de microbiota fecal en infeccion recurrente por Clostridium difficile. [Fecal microbiota transplantation in recurrent Clostridium difficile infection]. Experiencia local a partir de un caso clínico. Revista médica de Chile.2015; 144(4). https://n9.cl/9opv8
Frcpc DKM, Brandi Roach RN, Silva M, Frcpc PBM, Frcpc KRM, Kaplan MD FRCPC G, et al. Effect of Oral Capsule-vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection. Journal of the American medical. 2017;318(20):1986–92.
Cruz Ricardo, Monrroy Hugo, Flandez Jorge, Pérez Carlos M., Álvarez-Lobos Manuel, Hernández-Rocha Cristian. Claves prácticas para un trasplante de microbiota fecal por colonoscopía en infección por Clostridium difficile recurrente.[ Practical keys for a fecal microbiota transplant by colonoscopy in recurrent Clostridium difficile infection]. Experiencia en un centro universitario. Revista Chilena de infectología. 2018; 35(5): 566-573. https://n9.cl/phlu3
García-García-de-Paredes A, Rodríguez-de-Santiago E, Aguilera-Castro L, Ferre-Aracil C, López-Sanromán A. Trasplante de microbiota fecal. Gastroenterología y hepatología [Fecal microbiota transplant. Gastroenterology and hepatology]. 2015;38(3):123–4. https://n9.cl/3s1nj
Wadhwa A, Nahhas M F Al, Dierkhising RA, Patel R, Kashyap P, Pardi D S, et al. High risk of post-infectious irritable bowel syndrome in patients with Clostridium difficile infection. Aliment Pharmacol Ther 2016; 44: 576-82. doi: 10.1111/apt.13737.
Varier R U, Biltaji E, Smith K J, Roberts M S, Jensen M K, LaFleur J, et al. Cost-effectiveness analysis of treatment strategies for initial Clostridium difficile infection. Clin Microbiol Infect 2014; 20: 1343-51. doi: 10.1111/1469-0691.12805.
Published
How to Cite
Issue
Section
License
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
OAI-PMH: https://fundacionkoinonia.com.ve/ojs/index.php/saludyvida/oai.
